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Supporting tables and figures 
 
Table S1: Plasmids used in this study 
	  
 
 
 
  
Plasmid	   Description	  &/or	  Construction	   Reference	  
pSRKGm	   Complementation	  plasmid	  modified	  from	  pBBR1MCS-­‐5;	  GmR	  
	  
(Khan	  et	  al.,	  
2008)	  
pJQ200KS	   Mobilizable	  suicide	  vector;	  sacB,	  GmR	  
	  
(Quandt	  and	  
Hynes,	  1993)	  
pAB314	   pJQ200KS-­‐derivative	  utilized	  for	  chromosomal	  integration	  of	  DNA	  at	  
the	  glmUSX-­‐recG	  locus	  of	  R.	  palustris	  TIE-­‐1	  
	  
(Bose	  and	  
Newman,	  2011)	  
pGK224	   Cloned	  SphI/SmaI	  fragment	  of	  pAB314	  without	  intergenic	  SpeI	  site	  
into	  SphI/NotI-­‐cut	  pJQ200KS	  using	  primers	  pAB314upfor,	  
pAB314uprevfusion,	  pAB314dnforfusion,	  and	  pAB314dnrev	  
	  
This	  study	  
pGK225	   Cloned	  Plac-­‐lacI-­‐Plac-­‐lacZalpha	  from	  pSRKGm	  flanked	  by	  Fd	  and	  T7	  
terminators	  into	  NcoI-­‐cut	  pGK224	  using	  primers	  lacIforw/Fd	  and	  
lacIrevw/T7	  
	  
This	  study	  
pGK226	   Cloned	  R.	  palustris	  TIE-­‐1	  hpnP	  coding	  region	  into	  NdeI/AscI-­‐cut	  
pGK225	  using	  hpnPfor	  and	  hpnPrev	  
This	  study	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Table S2: Primers used in this study 
	  
Primer	   Sequence	   In	  bold	  
pAB314upfor	   GGCGCGCCGCATGCCACACCGGCAGGTTG	   AscI/SphI	  
	  
pAB314uprevfusion	   TTAGGTGCGGGTTAGTTACCACGCGTCATTTCGCGACCATGGCT
ACCCGACCTTGTCCGG	  
	  
-­‐	  
pAB314dnforfusion	   CCGGACAAGGTCGGGTAGCCATGGTCGCGAAATGACGCGTGGT
AACTAACCCGCACCTAA	  
	  
-­‐	  
pAB314dnrev	   ACTAGTGCGGCCGCCGAGATCGATTTTCTGGTCGGCAC	  
	  
SpeI/NotI	  
lacIforw/Fd	   ACTAGTCCATGGTAAACCGATACAATTAAAGGCTCCTTTTGGAG
CCTTTTTTTTTGGAGTGATTGACACCATCGAATGGTG	  
	  
SpeI/NcoI/Fd	  
terminator	  
lacIrevw/T7	   ACTAGTCCATGGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCC
CAAGGGGTTATGGCGCGCCTTACAATTTCCATTCGCCATTC	  
	  
SpeI/NcoI/T7	  
terminator/AscI	  
hpnPfor	   GAGATATACATATGAAAGCCGAATCCGGGCAGA	   NdeI	  
hpnPrev	   ACTAGTGGCGCGCCCTACTCCGCCGGCACCGCCGCTTC	   SpeI/AscI	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Table S3. Growth conditions for optimization of 2Me-BHT production in R. palustris TIE-1 WT and 
strain DKN1283. Total lipid extract from each culture was analysed by GC-MS.  
 
	   	   %	  of	  all	  hopanoids	   	   	   	  
WT+light	   OD600	  
2Me-­‐diplopterol	  
(5)	  
Diplopterol	  
(2)	  
2Me-­‐BHT	  
(15)	  
BHT	  
(13)	   %2MeBHT*OD600	  
YPMS	   0.98	   22	   39	   3	   36	   2.5	  
YPMS-­‐B12	   0.97	   21	   39	   2	   37	   1.8	  
YPMS-­‐Met	   1.15	   22	   38	   1	   39	   1.5	  
YPMS-­‐squalene	   1.01	   18	   34	   1	   47	   1.4	  
YPMS-­‐acetate	   1.48	   21	   20	   6	   53	   9.2	  
	   	   	   	   	   	   	  
WT	  w/o	  light	   	   	   	   	   	   	  
YPMS	   0.40	   16	   49	   2	   33	   0.7	  
YPMS-­‐B12	   0.45	   18	   43	   3	   35	   1.4	  
YPMS-­‐Met	   0.41	   12	   46	   2	   40	   0.7	  
YPMS-­‐squalene	   0.43	   10	   46	   1	   42	   0.6	  
YPMS-­‐acetate	   0.63	   19	   32	   4	   46	   2.3	  
	   	   	   	   	   	   	  
1283+light	   	   	   	   	   	   	  
YPMS	   0.98	   14	   46	   2	   38	   1.5	  
YPMS-­‐B12	   1.00	   19	   48	   2	   32	   1.6	  
YPMS-­‐Met	   0.99	   26	   38	   1	   34	   1.2	  
YPMS-­‐squalene	   1.08	   20	   48	   2	   31	   1.9	  
YPMS-­‐acetate	   1.46	   28	   44	   10	   19	   14.7	  
	   	   	   	   	   	   	  
1283	  w/o	  light	   	   	   	   	   	   	  
YPMS	   0.32	   22	   36	   3	   38	   1.1	  
YPMS-­‐B12	   0.38	   25	   33	   6	   36	   2.3	  
YPMS-­‐Met	   0.40	   24	   31	   4	   40	   1.7	  
YPMS-­‐squalene	   0.40	   22	   38	   3	   37	   1.1	  
YPMS-­‐acetate	   0.73	   35	   18	   9	   37	   6.9	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Figure S1. Growth curves of R. palustris TIE-1 WT and strain DKN1283 in 96-well plates in the 
absence or presence of light in different growth media. Error bars represent standard deviation 
of four replicates. 
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Figure S2. Optimization of 2Me-BHT production under different growth conditions evaluated by 
percentage of 2Me-BHT in total hopanoids (A and C), and the ratio of 2Me-BHT/BHT (B and D). 
Time course of these two factors from the cells grown in 50 mM MOPS, 20 mM succinate and 
40 mM acetate is shown (E). Error bars represent standard deviation of three biological 
replicates. 
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Figure S3: LC-MS of purified hopanoids. A/C: chromatograms of 
underivatized/acetylated samples; Y-axis shows the absolute signal intensity from MS; 
retention time and identity of the dominant peak is indicated in each chromatogram. 
B/D: MS spectra of the dominant peaks in A/C.  
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Figure S4. 1H NMR spectra of crude products in the conversions of 1 to 7 under the 
conditions indicated. 
 
Note: For general and individual conditions, refer to “Small-scale screening of 
conditions”. The Lewis acid/catalysts used and temperatures applied are as follows: 1, 
AlCl3, 0.25 eq., 65 °C; 2, AlCl3 + POCl3, 0.25 eq. of each reagent, 65 °C; 3, InCl3, 0.25 
eq., 65 °C; 4, ZnCl2, 0.25 eq., 65 °C; 5, ZrCl4, 0.25 eq., 65 °C; 6, CuCl, 0.25 eq., 65 °C; 
7, PdCl2, 0.25 eq., 65 °C; 8, CoCl2, 65 °C; 9, CuCl, 0.5 eq., 65 °C; 10, CuCl2, 0.25 eq., 
65 °C; 11, NiCl2, 0.25 eq., 65 °C; 12, TiCl4, 0.25 eq., 65 °C; 13, PdCl2, 0.25 eq., reflux; 
14, PdCl2, 1.25 eq. reflux; 15, POCl3, excess (Dunstan et al., 1957); 16, PdCl2, 0.25 eq., 
80 °C; 17, PdCl2, 1.25 eq. 80 °C; 18, Re2O7, 0.05 eq., RT(Korstanje et al., 2012).  
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General experimental information in chemical synthesis 
Melting points were recorded on a Kofler hot stage and are uncorrected. Proton nuclear 
magnetic resonance spectra were recorded on a DRX 500 (500 MHz), Bruker AC 500 
(500 MHz) or Bruker AV700 (700 MHz) spectrometer, as indicated. Carbon nuclear 
magnetic resonance spectra were recorded on a DRX 500 (126 MHz), Bruker AC 500 
(126 MHz) or Bruker AV700 (176 MHz) with a 13C cryoprobe (125 MHz). Spectra were 
fully assigned using a combination of COSY, HSQC, and DEPT 135, HMBC. All 
chemical shifts were quoted on the scale in ppm using residual solvent as the internal 
standard. Coupling constants (J) are reported in Hertz (Hz). Identical proton coupling 
constants are averaged in each spectrum and reported to the nearest 0.1 Hz. Where 
appropriate, resonances for axial protons are denoted “a” and resonances for equatorial 
protons are denoted “e”. Infrared spectra were recorded on a Bruker Tensor 27 Fourier 
Transform spectrophotometer with absorption maxima recorded in wavenumbers (cm-1). 
Oils were analyzed as thin films. Low resolution mass spectra were recorded on an LCT 
Premier XE using electrospray ionization (ES). High resolution mass spectra were 
recorded on a Bruker micrOTOF. Specific rotations were measured on a Perkin Elmer 
241 polarimeter with a pathlength of 1.0 dm with concentrations (c) given in g/100 mL 
(equivalent to g/0.1 dm3). Specific rotations are denoted as [α] D
T and are given in implied 
units of 10-1 deg cm2 g-1 (T = ambient temperature in °C). Thin layer chromatography 
(TLC) was carried out on Merk Kieselgel 60F254 precoated aluminum backed plates 
and visualized with a combination of the following: 254 nm UV lamp; molybdate staining 
(10 g ammonium molybdate, 360 mL water, 40 mL 18N H2SO4). Flash column 
chromatography was carried out with Fluka Kiegselgel 60 220-440 mesh silica gel. 
Anhydrous solvents (Toluene, CH2Cl2) were dried according to the procedure outlined 
by Pangborn et al. (Pangborn et al., 1996) and used without purification unless 
otherwise indicated. All other solvents were used as supplied (analytical or HPLC 
grade), without further purification. Petroleum ether refers to the fraction of petroleum 
ether boiling in the range 40-60 ºC.  Reagents and solvents used, unless otherwise 
stated, were of commercially available reagent grade quality and were used without 
further purification.  
 
Construction of hpnP overexpression strain DKN1283 
In an attempt to increase the production of 2-methylhopanoids, we expressed 
hpnP from an IPTG-inducible promoter on the chromosome. A modified version of the 
pAB314-based homologous recombination system was used to integrate lac promoter 
(Plac) driven hpnP at the permissive intergenic region of Rpal_2346 (glmX) and 
Rpal_2396 (recG). For this, the 2 Kb region around glmX-recG with a mutated SpeI site 
was sub-cloned from pAB314 into the parent plasmid pJQ200KS to give pGK224. The 
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lac repressor along with the IPTG-inducible Plac (Plac-lacI-Plac-lacZalpha) with flanking 
transcriptional terminators Fd and T7, was then sub-cloned from pSRKGm into pGK224 
to give pGK225. Finally, the hpnP coding region was cloned downstream of Plac to give 
the overexpression plasmid pGK226. pGK226 was transformed into WT R. palustris 
TIE-1 using gentamicin selection. The pGK226-integrants were then resolved using 
sucrose counterselection to obtain markerless DKN1283.  
Improvements on hopanoid purification from R. palustris TIE-1 
To purify hopanoids, we first applied protocols for analytical scale purification 
(Welander et al., 2012), which use solvents with increasing polarity to elute, in 
sequence, diploptene (8), (2Me)-diplopterol (2 and 5), and (2Me)-BHT (13 and 15). 
However, the dissolution of silica gel became a problem when using 4:1 EtOAc:MeOH. 
Unfortunately, this silica gel contamination could not be separated completely and 
replacing methanol with other polar solvents like acetone caused the same problem. To 
circumvent this issue, we derivatized the hydroxyl groups in (2Me)-BHT with a UV-
absorptive moiety such as benzoyl chloride, phenyl acetyl chloride, or hydrocinnamoyl 
chloride, to decrease BHT’s polarity and permit detection by HPLC equipped with a UV-
vis detector. However, the heterogeneity of the products prohibited a clean separation 
between methylated and unmethylated hopanoids. One primary alcohol-specific 
derivatization by tert-butyl(chloro)diphenylsilane was tested but the addition of a large 
functional group compromised the separation between 2Me-BHT and BHT. We then 
tested acetylation of hopanoids, which not only changed their polarity but also increased 
the solubility of (2Me)-BHT in DCM (CH2Cl2) dramatically, allowing more sample to be 
loaded onto the HPLC column. However, the acetylation of total lipid extract produced 
diplopterols with multiple acetyl groups that made the subsequent recovery of 
diplopterols after de-acetylation difficult. Therefore, our final protocol was to purify 
diplopterols from un-derivatized TLE and to acetylate the rest of the sample to purify 
acetylated BHTs. Silica gel purified (2Me)-diplopterol and acetylated (2Me)-BHT were 
then purified by HPLC using a single solvent composition. The final purified (2Me)-BHT 
was obtained after de-acetylation.  
Large scale total lipid extraction and hopanoid purification by silica gel and HPLC  
Briefly, the optimized conditions for extraction and purification of various 
hopanoids are as follows. Total lipid extract (TLE) from R. palustris TIE-1 strain 
DKN1283 was prepared using the Bligh-Dyer method (Bligh and Dyer, 1959) and 
modified for large-scale extraction. In a 4 L glass beaker, cell paste was suspended in 
water to reach a final volume of 5 mL solution per gram of wet cell paste. Then the 
equivalent of 12.5 mL methanol (MeOH) and 6.25 mL CH2Cl2 per gram of wet cell paste 
were added in sequence and stirred for 1 h before sonication for a total pulse time of 1 h 
while stirring (1/8 inch tip, power output 3.5, 1 sec on, 4 sec off, 4 °C, Sonic 
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Dismembrator 550, Fisher Scientific). After the sonicated sample was warmed to room 
temperature (RT), CH2Cl2 was added at a volume ratio of sample: CH2Cl2=4:3. After 
gentle stirring, the sample was allowed to settle for a few hours to overnight, permitting 
the organic and aqueous layer to separate. The bottom organic layer (dark brown) was 
collected and dried in a rotary evaporator. A typical dark green TLE was obtained. For 
silica gel purification, TLE was dissolved in CH2Cl2 and adsorbed on to Celite 545 (4 g 
per 1 g of TLE) using a rotary evaporator.  About 7 g of Celite-adsorbed TLE was 
loaded onto a column packed with ~300 mL of silica gel (~25 cm × 4 cm) pre-
equilibrated with hexane (Hex). The column was eluted in sequence of ~450 mL 
hexane, ~600 mL 3:1 hexanes:EtOAc, and ~200 mL pyridine. The presence of 
diploptene, diplopterols, and BHTs in each respective elution was monitored by TLC 
plates and visualized by molybdate staining (10 g ammonium molybdate, 360 mL water, 
40 mL 9M H2SO4) after heating on a hot plate (diploptene Rf~0.97, (2Me)-diplopterol (2 
and 5) Rf~0.51 in 5:1 hexanes:EtOAc, and (2Me)-BHT Rf~0.88 in 1:8:10 
water:IPA:EtOAc). As the solubility of (2Me)-BHT (13 and 15) is too low for downstream 
HPLC purification, the sample was acetylated to increase solubility. The fractions 
containing (2Me)-BHT were dried in a rotary evaporator and acetylated in 20 mL 
pyridine and 20 mL acetic anhydride at 60 °C for ~1.5 h. The acetylated BHTs were 
dried in the presence of Celite and packed onto a silica gel column as previously 
described. The column was equilibrated with ~500 mL of 8:1 hexanes:EtOAc and eluted 
with ~500 mL of 5:1 hexanes:EtOAc and then ~500 mL of 4:1 hexanes:EtOAc. The 
presence of (2Me)-BHT-4Ac was monitored by the same TLC method as above 
(Rf~0.21 in 5:1 hexanes:EtOAc). Further separation between methylated and 
unmethylated hopanoids was carried out using reverse phase HPLC (Phenomenex 
Luna C18(2), 100 Å, 5 µm, 250 × 21.2 mm column coupled with a Shimadzu LC-8A 
preparatory pump and a Beckman SC 100 fraction collector). The silica gel purified 
(2Me)-diplopterol samples were dried and re-dissolved at 1 g per mL of CH2Cl2 and 
about 100 mg was injected into the HPLC, pre-equilibrated in 95:5 MeOH:water and 
eluted with the same solvent at 20 mL/min. The silica gel purified (2Me)-BHT-4Ac were 
purified by HPLC as above except the column was pre-equilibrated in 65:35 IPA:water 
and eluted with the same solvent at 12 mL/min. HPLC-purified BHT-4Ac (14) and 2Me-
BHT-4Ac were collected and dried in a rotary evaporator. The samples were de-
acetylated by dissolution in 1:1 CH2Cl2:MeOH with a substoichiometric amount of 
sodium methoxide and incubated stirring at RT overnight. The products were passed 
through an Amberlite IR-120 column (hydrogen form, washed extensively with water, 
then dried with acetone, and packed in MeOH) and eluted with MeOH to exchange the 
by-product sodium acetate to acetic acid, which was subsequently removed along with 
solvent in a rotary evaporator. 
UPLC-ESI-TOF-MS analysis of hopanoids 
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To analyze the unacetylated or acetylated hopanoids by LC-MS, protocols based 
on Waters Application Note with modifications were followed (Isaac et al., 2011).  The 
samples were dissolved sonication in isopropanol:acetonitrile:water (2:1:1) at a final 
concentration of 1 mg/mL. The samples (5 µl/injection, three replicates per sample, all in 
randomized order) were separated by a charged surface hybrid C18 column (Waters 
Acquity UPLC CSH C18, 2.1 x 100 mm, 1.7 µm) and analyzed by Waters LC-MS/MS 
system (Acquity I-Class UPLC with Xevo G2-S TOF). The column temperature was 
maintained at 55 °C. A binary solvent system containing solvent A (acetonitrile:water; 
60:40) and solvent B (isopropanol:acetonitrile; 90:10), both with 10 mM ammonium 
formate and 0.1% formic acid was used. The flow rate was set at 400 µL/min and the 
elution program started at 40% B, increased linearly to 43% B in 2 min, then to 50% B in 
0.1 min, followed by linear increase to 54% B over 9.9 min, then jumped to 70% B in 0.1 
min, increased linearly to 99% B over 5.9 min, then decreased immediately to 40% B in 
0.1 min, and maintained at the same level for 1.9 min. 
 The eluents from the column were ionized by electrospray ionization (ESI).  MSE 
data from 100 to 1500 m/z was collected in either positive or negative ion mode. MSE 
consists of both low energy and high energy scans obtained simultaneously. During 
data analysis product ions can be associated with parent ions if they are coincident in 
chromatographic time. Electrospray conditions were capillary voltage 2.0 kV, cone 
voltage 30 V, source offset 60 V, source temperature 120 °C, desolvation temperature 
550 °C, cone gas 20 L/h, and desolvation gas 900 L/h. The TOF-MS was operated in 
resolution mode, typically 32,000 m/Δm. The mass axis was calibrated with sodium 
formate clusters. Leucine enkephalin was used as a mass reference during acquisition. 
The data were collected in continuum mode, and then converted to centroid mode for 
quantitative analysis using the Quanlynx program (Waters Corporation, Milford, MA). 	  
 
Screening of conditions for better production of 3-Oxo-diploptene (7) 
Small-scale screening of conditions: 
Conditions 1-17 in Figure S4: 1 (5 mg, 12 µmol) was dissolved in anhydrous toluene 
(2 mL) with 3 Å molecular sieves (MS). The Lewis acid/catalyst was added to the 
solution which was then heated to 65/80 °C, or under reflux. TLC analysis was 
employed to monitor the reactions. Typically, full conversion of 1 was observed within 2 
hours. The MS and catalysts were filtered through Celite, followed by washing with 
CH2Cl2 and concentration in vacuo. The resulting solid was dried in vacuo and then 
dissolved in CD2Cl2 and subjected to 1H NMR analysis.  
Condition 18 in Figure S4: 1 (30 mg, 68 µmol) was dissolved in anhydrous toluene 
(5 mL). Re2O7 (Corbett and Smith, 1967) (1.7 mg, 3.5 µmol) was added to the solution, 
which was then heated to 100 °C. Compound 1 was fully consumed, as indicated by 
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TLC analysis. The solution was filtered through Celite, followed by washing with CH2Cl2 
and concentration in vacuo. The resulting solid was dried in vacuo and then dissolved in 
CD2Cl2 and subjected to 1H NMR analysis. 
The optimum condition in small-scale screening was found to be 0.25 eq. PdCl2, 80 °C, 
2 h, which gave 43% of 7 in the crude products. 
Large-scale optimization 
After further trials on larger scales, it was found that the optimum conditions for 
converting 1-2 gram of 1 to 7 were 0.5 eq. PdCl2, 70 °C, 5 h, which gave ~40% (yield 
obtained after Ag coated silica chromatography followed by crystallization) of 7 from 
CH2Cl2 and hexane. 
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Characterization and experimental procedures  
Hydroxyhopanone-C30 (1) 
	    
Dammar resin (1 kg) was ground into powder, which was poured into methanol (6 L) 
(Dunstan et al., 1957). The suspension was boiled for 1 hour with stirring and then left 
overnight without stirring at RT. Undissolved materials were removed by filtration. The 
solvent was evaporated on a rotary evaporator. The resulting solid was dissolved in 
diethyl ether (8 L). The organic solution was washed with an aqueous solution of 
potassium hydroxide (5%, 1.5 L) and then water. The resulting organic solution was 
dried over magnesium sulfate, filtered and the filtrate was transferred into 4 glass 
bottles (2 L). The bottles were then placed on ice. Half of the solvent was removed 
under a slow, continuous stream of nitrogen. The remaining solution was combined into 
a 4 L bottle. The solvent was further evaporated on ice until ~1 L solution was left. 
Colorless solids were found attached on the inner walls of the bottle. The bottle was 
sealed and placed in a fridge. After three days, the precipitate was removed by filtration. 
The resultant colorless solid was washed with a small amount of cold ether. The solid 
was dissolved in ether and slowly crystallized in methanol. The crystals were then 
collected and dried to afford hydroxyhopanone (1) as colorless needles (7.7 g, 0.77 %): 
Rf 0.35 (hexanes: diethyl ether = 1: 1); [α] D
20  = +70 (c = 0.5, dichloromethane) (Lit. +64 
(Dunstan et al., 1957));  m.p. 275-277 °C (diethyl ether) (Lit. 252-256 °C, (acetone) 
(Dunstan et al., 1957)); νmax (ATR)/cm-1 3469, 2991 (νO-H), 2946, 2888, 2863 (νC-H), 
1708 (νC=O), 1444, 1377 (νC-H), 1147 (νC-O), 828 (νC-H); 1H NMR (700 MHz, CD2Cl2) δ 
0.76 (s, 3H, H-28), 0.93 (s, 3H, H-25), 0.95 (d, 1H, J 2.5 Hz, H-19a), 0.96 (s, 3H, H-27), 
0.99 (s, 3H, H-23), 1.01 (s, 3H, H-26), 1.04 (s, 3H, H-24), 1.14 (s, 3H, H-30), 1.18 (s, 
3H, H-29), 1.24-1.29 (m, 2H, H-15a & H-7e), 1.29-1.35 (m, 2H, H-5 & H-9), 1.36-1.55 
(m, 13H, H-11e, H-1e, H-13, H-15e, H-12a, H-6a, H-12e, H-17, H-20a, H-6e, H-11a, H-
7a, H-19e), 1.71-1.78 (m, 1H, H-20e), 1.89-1.96 (m, 2H, H-16e & H-1a), 2.20 (dt, 1H, J 
9.0, 11.0 Hz, H-21), 2.32-2.37 (m, 1H, , H-2e), 2.48 (m, 1H, H-2a); 13C NMR (176 MHz, 
CD2Cl2) δ 15.9 (C-25), 16.4 (C-28), 16.6 (C-26), 17.0 (C-27), 20.1 (C-6), 21.3 (C-23), 
21.9 (C-11), 22.3 (C-16), 24.5 (C-12), 26.7 (C-24), 26.9 (C-20), 29.0 (C-30), 31.1 (C-
29), 33.0 (C-7), 34.6 (C-2), 34.8 (C-15), 37.2 (C-10), 39.9 (C-1), 41.6 (C-19), 42.0 (C-8), 
42.3 (C-14), 44.4 (C-18), 47.6 (C-4), 50.0 (C-9), 50.4 (C-13), 51.5 (C-21), 54.4 (C-17), 
55.2 (C-5), 73.9 (C-22), 217.8 (C-3); HRMS m/z (FI) [Calculated for C30H50O2 424.3811; 
found 424.3897].  
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Diplopterol (hydroxyhopane, 2) 
	    
To 1 (500 mg, 1.13 mmol, 1.0 eq.) in a glass flask was added diethylene glycol (50 mL) 
and hydrazine hydrate (3.6 mL, 72 mmol, 62 eq.) under reflux for 2 hours (Dunstan et 
al., 1957). The excess of hydrazine and water was removed by distillation. Potassium 
hydroxide (1.3 g, 23 mmol, 20 eq.) was added and the solution was heated to 200-210 
ºC for 6 hours. After dilution with water, the product was extracted by an ether/water 
extraction. Evaporation of diethyl ether afforded a solid that was crystallized from 
acetone-methanol to afford diplopterol 2 as colorless solid (462 mg, 95%): Rf 0.55 
(hexanes: diethyl ether = 1: 1); [α] D
20  = +47.4 (c = 0.5, diethyl ether) (Lit. +45 (Dunstan et 
al., 1957)); m.p. 252-254 °C (diethyl ether-methanol) (Lit. 254-255 °C, acetone-
methanol (Dunstan et al., 1957)); νmax (ATR)/cm-1 3385, 2991(νO-H), 2944, 2866 (νC-H), 
1459, 1443, 1387, 1376 (νC-H), 1130 (νC-O); 1H NMR (700 MHz, CD2Cl2) δ 0.74 (dd, 1H, 
J 1.5, 12.0 Hz, H-5), 0.76 (s, 3H, H-28), 0.76-0.81 (m, 1H, H-1a), 0.80 (s, 3H, H-23), 
0.82 (s, 3H, H-25), 0.85 (s, 3H, H-24), 0.95 (dd, 1H, J 2.8, 12.4 Hz, H-19a) 0.96 (s, 3H, 
H-27), 0.97 (s, 3H, H-26), 1.10-1.16  (m, 1H, H-3a), 1.14 (s, 3H, H-30), 1.18 (s, 3H, H-
29), 1.19-1.28 (m, 3H, H-7a, H-15a, H-9), 1.29-1.43 (m, 7H, H-12a, H-6a, H-3e, H-2e, H-
13, H-15e,  H-1e), 1.43-1.63 (m, 8 H, H-17, H-11a, H-7a, H-20a, H-19e, H-12e, H-16a, H-
2a), 1.65 (dt, 1H, J 3.5, 12.7 Hz, H-1e), 1.70-1.77 (m, 1H, H-20e), 1.92 (m, H-16e), 2.20 
(m, 1H, H-21); 13C NMR (125 MHz, CD2Cl2) δ 16.0 (C-25), 16.3 (C-28), 16.9 (C-26), 
17.2 (C-27), 19.10 (C-6), 19.11 (C-2), 21.3 (C-12), 21.7 (C-23), 22.3 (C-16), 24.5 (C-
11), 27.0 (C-20), 29.0 (C-30), 31.1, (C-29), 33.54 (C-4), 35.55 (C-24), 33.61 (C-7), 34.8 
(C-15), 37.8 (C-10), 40.7 (C-1), 41.6 (C-19), 42.2 (C-8), 42.3 (C-14), 42.5 (C-3), 44.5 
(C-18), 50.2 (C-13), 50.8 (C-9), 51.6 (C-21), 54.3 (C-17), 56.4 (C-5), 74.0 (C-22). HRMS 
m/z (FI) [Calculated for C30H52O 428.4018; found 428.4015].  
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2,2-D2-Hydroxyhopanone (3) 
	    
Compound 1 (250 mg, 0.57 mmol, 1.0 eq.) was dissolved in CD2Cl2 (15 mL), MeOD 
(5.0 mL) and deuterium oxide (D2O, 0.75 mL) in a glass flask. NaOD in D2O (40 wt.%, 
40 µL, 1.0 eq.) was added. The reaction was kept overnight under stirring and then 
quenched by a dry carbon dioxide flow. The deuterated product was extracted by an 
ether/water extraction. The organic fraction was dried over magnesium sulfate and 
filtered. The solvent was removed from the filtrate on a rotary evaporator to afford 
product 3 as colorless crystals in 100% yield (250 mg): Rf 0.35 (hexanes: diethyl ether = 
1: 1); [α] D
20  = +61.2 (c = 0.5, dichloromethane); m.p. 254-257 (CH2Cl2); νmax (ATR)/cm-1 
3472 (νO-H), 2991, 2946, 2890, 2856 (νC-H), 1704 (νC-O), 1444, 1377 (νC-H), 1149,1081 
(νC-O), 827 (νC-H); 1H NMR (700 MHz, CD2Cl2) δ 0.76 (s, 3H, H-28), 0.93 (s, 3H, H-25), 
0.95 (d, 1H, J 2.5 Hz, H-19a), 0.96 (s, 3H, H-27), 0.99 (s, 3H, H-23), 1.01 (s, 3H, H-26), 
1.04 (s, 3H, H-24), 1.14 (s, 3H, H-30), 1.18 (s, 3H, H-29), 1.24-1.29 (m, 2H, H-15a & H-
7e), 1.29-1.35 (m, 2H, H-5 & H-9), 1.36-1.55 (m, 13H, H-11e, H-1e, H-13, H-15e, H-12a, 
H-6a, H-12e, H-17, H-20a, H-6e, H-11a, H-7a, H-19e), 1.69-1.79 (m, 1H, H-20e), 1.91 (d, 
1H, J 13.2 Hz, H-1a), 1.87-1.97 (m, 1H, H-16e), 2.20 (dt, 1H, J 9.0, 11.1 Hz, H-21); 13C 
NMR (125 MHz, CD2Cl2) δ 15.9 (C-25), 16.4 (C-28), 16.6 (C-26), 17.0 (C-27), 20.1 (C-
6), 21.3 (C-23), 21.9 (C-11), 22.3 (C-16), 24.5 (C-12), 26.7 (C-24), 26.9 (C-20), 29.0 (C-
30), 31.1 (C-29), 33.0 (C-7), 34.8 (C-15), 37.2 (C-10), 39.8 (C-1), 41.6 (C-19), 42.0 (C-
8), 42.3 (C-14), 44.4 (C-18), 47.6 (C-4), 50.0 (C-9), 50.4 (C-13), 51.5 (C-21), 54.4 (C-
17), 55.2 (C-5), 73.9 (C-22), 217.9 (C-3); HRMS m/z (FI) [Calculated for C30H48D2O2 
444.3936; found 428.3932]; Calculated with the signals in mass spectrometry using 
Force Ionization (FI) D2:D1:D0 = 86%: 18%: 6%. 
 
2,2,3,3-D4-Diplopterol (4) 
	    
Compound 3 (145 mg, 326 µmol, 1.0 eq.) was dissolved in a mixture of MeOD and D6-
toluene (10 + 20 mL). 4-Toluenesulfonyl hydrazide (303 mg, 1.63 mmol, 5.0 eq.) was 
added to the solution, followed by heating under reflux with a Soxhlet condenser filled 
with activated 3 Å molecular sieves. After 4 hours, the solution was cooled to RT. 
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NaBD4 (27 mg, 652 µmol, 2.0 eq.) was added. After heating under reflux for a further 2 
hours, the solution was cooled to RT and concentrated on a rotary evaporator. The 
resulting solid was subjected to silica chromatography (petroleum ether: diethyl ether = 
11: 2) to afford compound 4 as a colorless solid (62 mg, 44%): Rf 0.55 (hexanes: diethyl 
ether = 1: 1); [α] D
20  = +36.5 (c = 0.2, diethyl ether); m.p. 253-255 °C (diethyl ether); νmax 
(ATR)/cm-1 3472 (νO-H), 2946, 2867 (νC-H), 1466, 1386, 1372 (νC-H); 1H NMR (500 MHz, 
CD2Cl2) δ 0.73 (dd, 1H, J 1.8, 12.3 Hz, H-5), 0.75 (s, 3H, H-28), 0.74-0.78 (m, 1H, H-
1a), 0.79 (s, 3H, H-23), 0.82 (s, 3H, H-25), 0.84 (s, 3H, H-24), 0.90-0.95 (m, 1H, H-19a) 
0.96 (s, 3H, H-27), 0.97 (s, 3H, H-26), 1.14 (s, 3H, H-30), 1.17 (s, 3H, H-29), 1.18-1.28 
(m, 3H, H-7e, H-15a, H-9), 1.29-1.44 (m, 5H, H-12a, H-6a, H-13, H-15e, H-11e), 1.44-
1.56 (m, 5 H, H-17, H-11a, H-7a, H-20a, H-12e), 1.58 (dd, J 3.6, 12.3 Hz, H-16a), 1.60-
1.67 (m, 1H, H-1e), 1.69-1.78 (m, 1H, H-20e), 1.88-1.95 (m, H-16e), 2.15-2.25 (m, 1H, 
H-21); 13C NMR (125 MHz, CD2Cl2) δ 16.2 (C-25), 16.5 (C-28), 17.1 (C-26), 17.3 (C-27), 
19.2 (C-6), 21.5 (C-12), 21.9 (C-23), 22.5 (C-16), 24.7 (C-11), 27.1 (C-20), 29.1 (C-30), 
31.3 (C-29), 33.5 (C-4), 33.6 (C-24), 33.8 (C-7), 34.9 (C-15), 37.9 (C-10), 40.6 (C-1*), 
40.7 (C-1), 41.8 (C-19), 42.38, 42.43 (C-8, C-14), 44.6 (C-18), 50.4 (C-13), 50.9 (C-9), 
51.7 (C-21), 54.5 (C-17), 56.5 (C-5), 74.1 (C-22); HRMS m/z (FI) [Calculated for 
C30H48D4O 432.4269; found 432.4484].  
*C1 of the tri-deuterated compound (C1:C1*= ~3:1). Calculated with the signals in mass 
spectrometry using Force Ionization (FI) D4:D3:D2 = 55%: 37%: 8%. 
 
(3S)-3-Hydroxydiplopterol (6)  
	    
Compound 1 (100 mg, 226 µmol, 1.0 eq.) was dissolved in methanol and diethyl ether 
(10 mL;10 mL). NaBH4 (85 mg, 2.2 mmol, 9.7 eq.) was added. The reaction was stirred 
at RT for 1 h.  The solvent was evaporated. Diethyl ether (50 mL) and water (50 mL) 
were added to the resulting solid. The product was extracted with further diethyl ether (2 
× 50 mL). The organic phase was dried over anhydrous MaSO4, and filtered. The 
solvent was removed on a rotary evaporator, followed by crystallization from diethyl 
ether, to give 6 as small colorless needles (90 mg, 90%): Rf 0.22 (hexanes: diethyl ether 
= 1: 1); [α] D
20  = +38 (c =  0.15, CH2Cl2); m.p. 256-258 °C (diethyl ether); νmax (ATR)/cm-1 
3366 (νN-H, νO-H), 2942 (νC-H), 1448, 1374 (νC-H); 1H NMR (500 MHz, CD2Cl2) δ 0.69 (dd, 
1H, J 1.8, 11.9 Hz, H-5), 0.74 (s, 3H, C-24), 0.75 (s, 3H, C-28), 0.82 (s, 3H, C-25), 0.92-
0.98 (m, 11H, H-1a, H-19a, H-26, H-27, H-23), 1.14 (s, 3H, H-30), 1.17 (s, 3H, H-29), 
1.20-1.31 (m, 3H, H-9, H-7e, H-15a), 1.31-1.63 (m, 15H, H-12a, H-6a, H-11e, H-13, H-
15e, H-17, H-20a, H-7a, H-11a, H-6e, H-12e, H-19e, H-2, H-16a), 1.65-1.78 (m, 2H, H-
1e, H-20e), 1.89-1.96 (m, 1H, H-16e), 2.15-2.24 (m, 1H, H-21), 3.11-3.19 (m, 1H, H-3); 
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13C NMR (125 MHz, CD2Cl2) δ 15.6 (C-23), 16.1 (C-25), 16.4 (C-28), 16.9 (C-26), 17.2 
(C-27), 18.9 (C-6), 21.5 (C-12), 22.4 (C-16), 24.5 (C-11), 27.0 (C-20), 28.0 (C-2), 28.3 
(C-23), 29.1 (C-30), 31.2 (C-29), 33.7 (C-7), 34.9 (C-15), 37.6 (C-10), 39.1 (C-1), 39.2 
(C-4), 41.7 (C-19), 42.2 (C-8), 42.3 (C-14), 44.5 (C-18), 50.4 (C-13), 50.8 (C-9), 51.6 
(C-21), 54.4 (C-17), 55.5 (C-5), 74.0 (C-22), 79.2 (C-3); HRMS m/z (FI) [Calculated for 
C30H52O2 444.3967; found 444.4068].  
 
(2S)-2-Methyldiplopterol (5)  
  
Refer to Large scale total lipid extraction and Hopanoid purification by silica gel 
and HPLC (Page S9) for purification procedure. Characterization of 5: Rf 0.55 
(hexanes: diethyl ether = 1: 1); [α] D
20  = +88.8 (c = 0.17, diethyl ether); m.p. 193-195 °C 
(CH2Cl2)); νmax (ATR)/cm-1 3472 (νO-H), 2946, 2867 (νC-H), 1466, 1386, 1372 (νC-H);  1H 
NMR (500 MHz, CD2Cl2) δ 0.76 (H-28), 0.82 (d, 3H, J 6.0 Hz, H-31), 0.83 (s, 3H, H-25), 
0.85 (dd, 1H, J 2.8, 13.9 Hz, H-1a), 0.88 (s, 3H, H-24), 0.89 (s, 3H, H-23), 0.95 (br s, 
6H, H-24, H-27), 0.96 (s, 3H, H-26), 0.91 (dd, 1H, J 4.1, 8.8 Hz, H-5), 0.96 (dd, 1H, J 
6.4, 8.8 Hz, H-19a), 1.10-1.15 (m, 1H, H-3e), 1.14 (s, 3H, H-30), 1.17 (s, 3H, H-29), 
1.18-1.30 (m, 4H, H-7e, H-3a, H-15a, H-9), 1.34-1.62 (m, 14H, H-12a, H-6a, H-13, H-
15e, H-6e, H-11e, H-7a, H-17, H-1e, H-11a, H-12e, H-20a, H-19e, H-16a), 1.55-1.63 (m, 
1H, H-2), 1.70-1.77 (m, 1H, H-20e), 1.89-1.95 (m, 1H, H-16e), 2.15-2.24 (m, 1H, H-21); 
13C NMR (125 MHz, CD2Cl2) δ 16.6 (C-26, C-28),16.3 (C-27), 20.5 (C-6), 22.1 (C-23), 
22.4 (C-12), 22.5 (C-16), 23.5 (C-31), 25.0 (C-11), 25.3 (C-2), 26.4 (C-25), 27.1 (C-20), 
29.1 (C-30), 31.27 (C-24), 31.29 (C-29), 32.9 (C-4), 33.0 (C-7), 35.0 (C-15), 38.3 (C-
10), 41.8 (C-19), 42.4 (C-8), 42.5 (C-14), 44.6 (C-18), 45.7 (C-3), 50.1 (C-5), 50.3 (C-1), 
50.9 (C-13), 51.4 (C-9), 51.7 (C-21), 54.5 (C-17), 74.1 (C-22); HRMS m/z (FI) 
[Calculated for C31H54O 442.4175; found 442.4190]. 
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3-Oxo-diploptene (7) and 3-oxo-21-ene-deoxy-hopane (11) 
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To the solution of hydroxyhopanone (1) (2.0 g, 4.7 mmol, 1.0 eq.) in anhydrous toluene 
(200 mL) and CH2Cl2 (10 mL) with 3 Å MS was added PdCl2 (400 mg, 2.3 mmol. 
0.5 eq.). The reaction was kept under an atmosphere of argon at 70 °C for 5 hours. The 
suspension was filtered through Celite and the filtrate was concentrated. The residual 
material was subjected to Ag-coated silica chromatography (hexanes: Et2O = 20:1) to 
afford the desired product 3-oxo-diploptene (7) (0.8 g, 40%) as a colorless solid and the 
isomer 11 (0.3 g, 30%) as a colorless solid, which were further purified by 
crystallization, separately, from CH2Cl2 and hexane.  
Compound 7: Rf 0.33 (normal TLC, hexanes: diethyl ether = 9: 1) and 0.14 (Silver-
coated TLC, hexanes: diethyl ether = 9: 1); [α] D
20  = +84 (c = 0.25, CH2Cl2); m.p. 210-
212 °C (CH2Cl2-hexane); (Lit. 194 °C (acetone) (Dunstan et al., 1957)); νmax (ATR)/cm-1 
2946, 2862 (νC-H), 1705 (νC=O), 1645, 1632 (νC=C), 1444, 1376 (νC-H), 1005 (νC-O), 887 
(νC-H);  1H NMR (500 MHz, CD2Cl2) δ 0.73 (s, 3H, H-28), 0.93 (s, 3H, H-25), 0.95 (s, 3H, 
H-27), 1.00 (s, 3H, H-23), 1.01 (s, 3H, H-26), 1.04 (s, 3H, H-24), 1.01-1.09 (m, 1H, H-
19a), 1.22-1.69 (m, 18 H, H-15a, H-7e, H-5, H-9, H-1e, H-13, H-17, H-15e, H-12a, H-11e, 
H-6a, H-12e, H-11a, H-6e, H-7a, H-16a, H-19e, H-16e), 1.75 (s, 3H, H-30), 1.76-1.89 (m, 
2H, H-20), 1.88-1.96 (m, 1H, H-1a), 2.31-2.39 (m, 1H, H-2e), 2.43-2.52 (m, 1H, H-2a), 
2.65-2.74 (m, 1H, H-21), 4.77 (s, 2H, H-29); 13C NMR (125 MHz, CD2Cl2); δ 15.9 (C-25), 
16.3 (C-28), 16.5 (C-26), 16.7 (C-27), 20.1 (C-6), 21.3 (C-23), 21.9 (C-12), 22.0 (C-16), 
24.3(C-11), 25.1 (C-30), 26.6 (C-24), 27.7 (C-20), 33.0 (C-7), 34.0 (C-15), 34.5 (C-2), 
37.2 (C-10), 39.9 (C-1), 42.0 (C-8), 42.5 (C-14), 42.2 (C-19), 45.1 (C-18), 46.9 (C-21), 
47.5 (C-4), 49.9 (C-13), 50.0 (C-9), 55.1 (C-5), 55.2 (C-17), 110.2 (C-29), 149.1 (C-22), 
217.7 (C-3); HRMS m/z (FI) [Calculated for C30H48O 424.3705; found 424.3698]. 
Compound 11: Rf 0.32 (normal TLC, hexanes: diethyl ether = 9: 1) and 0.24 (Silver-
coated TLC, hexanes: diethyl ether = 9: 1); [α] D
20  = +54 (c = 0.5, CH2Cl2) (literature: +67 
(Dunstan et al., 1957)); m.p. 205-208 °C ( CH2Cl2-hexane) (Lit. 189-193 °C, acetone) 
(Dunstan et al., 1957)); νmax (ATR)/cm-1 2972, 2945, 2925, 2865 (νC-H), 1703 (νC=O), 
1680 (νC=C), 1459, 1383, 1372 (νC-H), 1001 (νC-O); 1H NMR (500 MHz, CD2Cl2) δ 0.59 (s, 
3H, H-28), 0.93 (s, 3H, H-25), 0.98 (s, 3H, H-27), 1.00 (s, 3H, H-23), 1.02 (s, 3H, H-
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1.04 (s, 3H, H-24), 1.27 (dt, 1H, J 3.3, 13.2 Hz, H-15a), 1.29-1.56 (m, 14H, H-7e, H-5, 
H-9, H-12a, H-1a, H-15e, H-6a, H-11e, H-11a, H-13, H-6e, H-7a, H-19e, H-12e), 1.57 (s, 
3H, H-29/30), 1.61 (td, 1H, J 3.7, 12.6 Hz, H-16a), 1.73 (s, 3H, H-30/29), 1.74-1.80 (m, 
1H, H-17), 1.89-1.96 (m, 1H, H-1e), 2,07 (dd, 1H, J 9.9, 16.3 Hz, H-20a), 2.13-2.26 (m, 
2H, H-16e, H-20e) 2.30-2.39 (m, 1H, H-2e), 2,43-2.53 (m, 1H, H-2a); 13C NMR (125 
MHz, CD2Cl2) δ 14.8 (C-28), 15.9 (C-25), 16.5 (C-26), 16.6 (C-27), 19.5 (C-29/30), 20.1 
(C-6), 21.3 (C-23), 21.9 (C-12), 22.9 (C-30/29), 23.7 (C-16), 24.0 (C-11), 26.7 (C-24), 
28.7 (C-20), 33.0 (C-7), 33.2 (C-15), 34.6 (C-2), 37.2 (C-10), 39.4 (C-19), 39.9 (C-1), 
41.9 (C-8), 42.0 (C-14), 44.7 (C-18), 47.6 (C-4), 48.6 (C-13), 50.1 (C-9), 55.2 (C-5), 
56.3 (C-17), 120. 9 (C-22), 135.9 (C-21), 217.7 (C-3); HRMS m/z (FI) [Calculated for 
C30H48O 424.3705; found 424.3720]. 
 
Diploptene (8) 
	  
Compound 7 (50 mg, 0.12 mmol, 1.0 eq.) was dissolved in toluene (20 mL) and 4-
toluenesulfonyl hydrazide (42 mg, 0.22 mmol, 1.8 eq.) was added. The solution was 
heated under reflux with a Soxhlet condenser filled with activated 3 Å molecular sieves 
for 2 hours. After this time, the solution was cooled to RT and NaBH4 (20 mg, 
0.53 mmol, 4.4 eq.) and methanol (5 mL) were added in two portions over a period of 10 
min. After heating under reflux for a further 30 min, the solution was cooled down to RT 
and concentrated on a rotary evaporator. The residual material was subjected to silica 
chromatography (hexane) to afford diploptene (8) as a colorless solid (41 mg, 82%) that 
was crystallized from hexane and methanol to give small needles: Rf 0.91 (normal TLC, 
hexanes: diethyl ether = 9: 1) and 0.59 (Silver-coated TLC, hexanes: diethyl ether = 9: 
1); [α] D
20  = +60 (c = 0.25, CH2Cl2) (Lit. +56.7 (c = 0.10, CHCl3 (Corbett and Smith, 
1967)); m.p. 199-201 °C (CH2Cl2-hexane) (Lit. 205 °C (hexane-ethanol) (Corbett and 
Smith, 1967) & 212-215 °C (Tsuda et al., 1967)); νmax (ATR)/cm-1 2943, 2925, 2867 (νC-
H), 1645 (νC=C), 1458, 1388 (νC-H), 886, 801 (νC-H);  1H NMR (500 MHz, CD2Cl2) δ 0.72 
(s, 3H, H-28), 0.70-0.77 (m, 2H, H-5, H-1a), 0.80 (s, 3H, H-23), 0.82 (s, 3H, H-25), 0.84 
(s, 3H, H-24), 0.95 (s, 3H, H-27), 0.97 (s, 3H, H-26), 1.00-1.09 (m, 1H, H-19a), 1.13 (td, 
1H, J 4.8, 14.0 Hz, H-3a), 1.17-1.30 (m, 3H, H-7e, H-15a, H-9), 1.30-1.43 (m, 8H, H-12a, 
H-6a, H-3e, H-2e, H-13, H-15e, H-11e, H-17), 1.43-1.68 (m, 9 H, H-11a, H-16a, H-7a, H-
6e, H-12e, H-2a, H-19e, H-16e, H-1e), 1.74 (s, 3H, H-30), 1.76-1.90 (m, 2H, H-20), 2.64-
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2.74 (m, 1H, H-21), 4.77 (s, 2H, H-29); 13C NMR (100 MHz, CD2Cl2) δ 16.0 (C-25), 16.3 
(C-28), 16.8 (C-26), 16.9 (C-27), 19.1 (C-2, C-6), 21.3 (C-12), 21.7 (C-23), 22.1 (C-16), 
24.4 (C-11), 25.1 (C-30), 27.8 (C-20), 33.55 (C-4), 33.56 (C-7),	  33.64 (C-24), 34.0 (C-
15), 37.8 (C-10), 40.7 (C-1), 42.2 (C-19), 42.3, 42.4 (C-8, C-14), 42.5 (C-3), 45.2 (C-18), 
47.0 (C-21), 49.8 (C-13), 50.8 (C-9), 55.3 (C-17), 56.4 (C-5), 110.2 (C-29), 149.3 (C-
22); HRMS m/z (FI) [Calculated for C30H50 410.3913; found 410.3913].    
 
2,2-D2-3-Oxo-diploptene (9) 
 
Compound 7 (100 mg, 0.24 mmol, 1.0 eq.) was dissolved in CD2Cl2 (5.0 mL), MeOD 
(1.67 mL) and D2O (0.25 mL) in a glass flask and NaOD in D2O (40 wt.%, 13 µL, 0.77 
eq.) was added. The reaction was kept overnight under stirring and then quenched by a 
dry carbon dioxide flow. The deuterated product was extracted by an ether/water 
extraction. The organic fraction was dried over magnesium sulfate and filtered. The 
solvent was removed on a rotary evaporator to afford product 9 as colorless crystals in 
100% yield (100 mg): Rf 0.33 (normal TLC, hexanes: diethyl ether = 9: 1) and 0.14 
(Silver-coated TLC, hexanes: diethyl ether = 9: 1); [α] D
20  = +78 (c = 0.25, CH2Cl2); m.p. 
219-221 °C (CH2Cl2); νmax (ATR)/cm-1 2947, 2927, 2856 (νC-H), 1703 (νC=O), 1647, 1632 
(νC=C), 1444, 1262 (νC-H), 1082 (νC-O), 801 (νC-H); 1H NMR (500 MHz, CD2Cl2) δ 0.73 (s, 
3H, H-28), 0.93 (s, 3H, H-25), 0.95 (s, 3H, H-27), 1.00 (s, 3H, H-23), 1.01 (s, 3H, H-26), 
1.04 (s, 3H, H-24), 1.02-1.09 (m, 1H, H-19a), 1.22-1.69 (m, 18 H, H-15a, H-7e, H-5, H-9, 
H-1a, H-13, H-17, H-15e, H-12a, H-11e, H-6a, H-12e, H-11a, H-6e, H-7a, H-16a, H-19e, 
H-16e), 1.75 (s, 3H, H-30), 1.76-1.89 (m, 2H, H-20), 1.88-1.95 (m, 1H, H-1e), 2.66-2.74 
(m, 1H, H-21), 4.78 (s, 2H, H-29); 13C NMR (125 MHz, CD2Cl2) δ 15.9 (C-25), 16.3 (C-
28), 16.6 (C-26), 16.8 (C-27), 20.1 (C-6), 21.3 (C-24), 21.9 (C-12), 22.0 (C-16), 24.3 (C-
11), 25.1 (C-30), 26.6 (C-23), 27.7 (C-20), 33.0 (C-7), 34.1 (C-15), 37.2 (C-10), 39.8 (C-
1), 42.0, 42.5 (C-8, C-14), 42.3 (C-19), 45.1 (C-18), 46.9 (C-21), 47.6 (C-4), 50.0 (C-13), 
50.1 (C-9), 55.2 (C-5), 55.3 (C-17), 110.2 (C-29), 149.2 (C-22), 217.9 (C-3); HRMS m/z 
(FI) [Calculated for C30H46D2O 426.3831; found 426.3822].   
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2,2,3,3-D4-diploptene (10) 
	  	  
Compound 9 (50 mg, 0.12 mmol, 1.0 eq.) was dissolved in toluene (20 mL). 4-
Toluenesulfonyl hydrazide (44 mg, 0.23 mmol, 1.9 eq.) was added to the solution, 
followed by heating under reflux with a Soxhlet condenser filled with activated 3 Å 
molecular sieves. After 2 hours, the solution was cooled to RT. NaBD4 (20 mg, 
0.48 mmol, 4.0 eq.) and MeOD (5 mL) were added in two portions over a period of 10 
min. After heating under reflux for a further 30 min, the solution was cooled to RT and 
concentrated on a rotary evaporator. The residual material was subjected to silica 
chromatography (hexane) to afford compound 10 as a cololess solid (45 mg, 90%) that 
was crystallized from hexane and mechanol to give small needles: Rf 0.91 (normal TLC, 
hexanes: diethyl ether = 9: 1) and 0.59 (silver-coated TLC, hexanes: diethyl ether = 9: 
1); [α] D
20  =+60 (c = 0.25, CH2Cl2); m.p. 209-210 °C (hexane-methanol); νmax (ATR)/cm-1 
2944, 2925, 2894, 2864 (νC-H), 1645, 1633 (νC=C), 1444, 1377 (νC-H), 886, 750 (νC-H); 1H 
NMR (500 MHz, CD2Cl2): δ 0.72 (s, 3H, H-28), 0.74-0.79 (m, 2H, H-5, H-1a), 0.79 (s, 
3H, H-23), 0.82 (s, 3H, H-25), 0.84 (s, 3H, H-24), 0.95 (s, 3H, H-27), 0.97 (s, 3H, H-26), 
0.99-1.11 (m, 1H, H-19a), 1.17-1.44 (m, 9H, H-7e, H-15a, H-9, H-12a, H-6a, H-13, H-
15e, H-17, H-11e), 1.43-1.68 (m, 8 H, H-16a, H-11a, H-7a, H-6e, H-12e, H-19e, H-16e, H-
1e), 1.75 (s, 3H, H-30), 1.76-1.90 (m, 2H, H-20), 2.64-2.73 (m, 1H, H-21), 4.77 (s, 2H, 
H-29); 13C NMR (126 MHz, CD2Cl2): 16.0 (C-25), 16.3 (C-28), 16.8 (C-26), 16.9 (C-27), 
19.1 (C-2, C-6), 21.3 (C-12), 21.7 (C-23), 22.1 (C-16), 24.4 (C-11), 25.1 (C-30), 27.8 (C-
20), 33.3 (C-4), 33.5 (C-24), 33.6 (C-7), 34.0 (C-15), 37.7 (C-10), 40.4 (C-1), 40.5 (C-
1*),  42.2 (C-19), 42.3 (C-8), 42.4 (C-14), 45.2 (C-18), 46.9 (C-21), 49.8 (C-13), 50.8 (C-
9), 55.3 (C-17), 56.4 (C-5), 110.2 (C-29), 149.3 (C-22); HRMS m/z (FI) [Calculated for 
C30H46D4 414.4164; found 414.4161]. 
*C1 of the tri-deuterated compound (C1:C1*= ~3:1). Calculated with the signals in mass 
spec with Force Ionization (FI) D4:D3:D2 = 65:31:4. 
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3-Oxo-17-ene-deoxy-hopane (12) 
	  
Refer to Screening of conditions for better production of 7 (condition 11) for 
experimental procedures. Characterization of compound 12: Rf 0.34 (normal TLC, 
hexanes: diethyl ether = 9: 1) and 0.22 (silver-coated TLC, hexanes: diethyl ether = 9: 
1); [α] D
20 = +63 (c = 0.1, CH2Cl2); m.p. 195-198 °C (CH2Cl2); νmax (ATR)/cm-1 2989, 2944, 
2855 (νC-H), 1706 (νC=O), 1663, 1632 (νC=C), 1459, 1448, 1379 (νC-H), 1002 (νC-O); 1H 
NMR (500 MHz, CD2Cl2) δ 0.59 (s, 3H, H-28), 0.92 (d, 3H, J 7.8 Hz, H-30), 0.93 (s, 3H, 
H-25), 0.97 (s, 3H, H-26), 0.98 (d, 3H, J 7.1 Hz, H-29), 1.00 (s, 3H, H-23), 1.05 (s, 3H, 
H-24), 1.06 (s, 3H, H-27), 1.27-1.60 (m, 15 H, H-15a, H-15e, H-19a, H-5, H-7e, H-11e, 
H-12a, H-9, H-1a, H-12e, H-6a, H-13, H-6e, H-7a, H-11a), 1.67 (dd, 1H, J 7.5, 11.7 Hz, 
H-19e), 1.88-1.99 (m, 2H, H-16a, H-1e), 2.12 (dd, 1H, J 9.4, 15.3 Hz, H-20a), 2.16-2.26 
(m, 1H, H-20e), 2.29 (dt, 1H, J 3.6, 14.3 Hz, H-16e), 2.33-2.41 (m, 1H, H-2e), 2.42-2.52 
(m, 1H, H-2a), 2.60-2.71 (m, 1H, H-22); 13C NMR (126 MHz, CD2Cl2) δ 15.0 (C-27), 16.2 
(C-26), 16.3 (C-25), 19.2 (C-28), 20.1 (C-6), 20.2 (C-16), 21.2 (C-23), 21.4 (30), 22.0 
(C-29), 22.3 (C-11), 24.4 (C-12), 26.8 (C-22, C-24), 27.8 (C-20), 32.2 (C-15), 33.2 (C-7), 
34.5 (C-2), 37.3 (C-10), 40.1 (C-1), 42.0 (C-8), 42.4 (C-14), 42.1 (C-19), 47.6 (C-18), 
49.9 (C-13), 50.2 (C-4), 50.5 (C-9), 55.2 (C-5), 136.6 (C-21), 140.3 (C-17), 217.9 (C-3); 
HRMS m/z (FI) [Calculated for C30H48O 424.3705; found 424.3539].  
 
Bacteriohopanetetrol (BHT, 13)  
 
Refer to Refer to Large scale total lipid extraction and Hopanoid purification by 
silica gel and HPLC (Page S9) for purification procedure. The optimized procedure to 
dissolve 13 NMR experiments was as follows. MeOD (1 mL) was added to BHT 
(7.2 mg), followed by vortex and solication. A slightly white gel was formed after 
overnight stand on the bench at RT. CDCl3 (1 mL each time) was added slowly to the 
gel, followed by strong vortex, sonication and short-time heating at 40 ºC repeatedly. 
After the addition of repetition of this step 5 times, a clear and colorless solution was 
formed.  Compound 13: Rf 0.88 (water: 2-propanol: EtOAc = 1:8:10);  [α] D
20 = +58.3 (c 
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0.12, CDCl3: MeOD = 5: 1); νmax (ATR)/cm-1 3340 (νN-H, νO-H), 2944, 2864 (νC-H), 1442, 
1378 (νC-H), 1085, 1014 (νC-O); 1H NMR (500 MHz, MeOD:CDCl3 = 1:5) δ 0.52-0.61 (m, 
1H, H-5), 0.59 (s, 3H, H-28), 0.65 (dd, 1H, J 3.4, 13.1 Hz, H-1a), 0.68 (s, 3H, H-23), 
0.71 (s, 3H, H-25), 0.74 (s, 3H, H-24), 0.74-0.81 (m, 1H, H-19a), 0.81-0.86 (m, 9H, H-
26, H-27, H-29), 0.94-1.06 (m, 1H, H-3a), 1.07-1.32 (m, 13H, H-7e, H-15a, H-30a, H-9, 
H-17, H-31a, H-12a, H-13, H-3e, H-15e, H-6a, H-2e, H-11e), 1.32-1.51 (m, 11H, H-11a, 
H-7e, H-30b, H-31b, H-2a, H-6e, H-12e, H-22, H-19e, H-16a, H-20a), 1.50-1.57 (m, 1H, 
H-1e), 1.58-1.75 (m, 3H, H-16e, H-21, H-20e), 3.37 (t, 1H, J 6.3 Hz, H-33), 3.49-3.68 (m, 
4H, H-32, H-34, H-35); 13C NMR (125 MHz, MeOD:CDCl3 = 1:5) δ 16.08 (C-28), 16.14 
(C-25), 16.7 (C-27), 16.8 (C-26), 18.97 (C-6), 18.99 (C-2), 20.2 (C-29), 21.3 (C-12), 
21.8 (C-23), 23.1 (C-16), 24.3 (C-11), 28.0 (C-20), 29.6 (C-31), 31.9 (C-30), 33.5 (C-4), 
33.59 (C-24), 3.63 (C-7), 34.0 (C-15), 37.2 (C-22), 37.7 (C-10), 40.6 (C-1), 41.9 (C-19), 
42.0 (C-8), 42.1 (C-14), 42.4 (C-3), 44.7 (C-18), 46.6 (C-21), 49.6 (C-13), 50.8 (C-9), 
54.8 (C-17), 56.5 (C-5), 63.6 (C-35), 73.3 (C-34), 74.1 (C-32), 74.8 (C-33); HRMS m/z 
(ES+) [Calculated for C35H62NaO4+ 569.4540; found 569.4547].   
 
32,33,34,35-tetra-O-Acetyl bacteriohopanetetrol (14)  
 
BHT (13) (2.0 mg, 3.7 µmol) was dissolved in pyridine (0.5 mL). Acetic anhydride (3 
drops, ~12 µL) was added. The reaction was kept under stirring for 6 hours. The solvent 
was removed on a rotary evaporator. The residual material was subjected to silica 
chromatography (petroleum: diethyl ether = 1: 4) to afford compound 14 as a wax-like 
material (2.1 mg, 81%): Rf 0.40 (hexanes: diethyl ether = 1: 1); [α] D
20 = +52 (c = 0.075, 
diethyl ether); νmax (ATR)/cm-1  2942, 2867 (νC-H), 1747 (νC=O), 1220 (νC-O); 1H NMR (700 
MHz, CDCl3) δ 0.69 (s, 3H, H-28), 0.71 (dd, 1H, J 1.5, 12.3 Hz, H-5), 0.76 (dd, J 3.5, 
12.9 Hz, H-1a), 0.79 (s, 3H, H-23), 0.81 (s, 3H, H-25), 0.85 (s, 3H, H-24), 0.87-0.91 (m, 
1H, H-19a), 0.91 (d, J 6.4 Hz, H-29), 0.94 (s, 3H, H-27), 0.95 (s, 3H, H-26), 1.11 (m, 2H, 
H-30a), 1.13 (td, J 4.0, 13.3 Hz, H-3a), 1.19-1.67 (m, 24H, H-7e, H-15a, H-9, H-17, H-
12a, H-6a, H-13, H-15e, H-3e, H-6e, H-11e, H-30b, H-20a, H-11a, H-22, H-7a, H-2e, H-
31a, H-19e, H-16a, H-12e, H-2a, H-31b, H-1e), 1.68-1.80 (m, 3H, H-16e, H-20e, H-21), 
2.05 (s, 3H, C-35-OCOCH3), 2.07 (s, 3H, C-32-OCOCH3), 2.079 (s, 3H, C-33-
OCOCH3), 2.084 (s, 3H, C-34-OCOCH3), 4.15 (dd, 1H, J 6.7, 12.2 Hz, H-35a), 4.38 (dd, 
1H, J 2.7, 12.2 Hz, H-35b), 5.03 (dt, 1H, J 3.8, 9.3 Hz, H-32), 5.23 (dd, 1H, J 4.4, 5.4 
Hz, H-33), 5.25-5.29 (m, 1H, H-34); 13C NMR (176 MHz, CDCl3) δ 16.0 (C-28), 16.1 (C-
25), 16.7 (C-27), 16.8 (C-26), 18.9 (C-2, C-6), 20.2 (C-29), 20.95 (C-33-OCOCH3), 
21.00 (C-34-OCOCH3), 21.12 (C-32-OCOCH3), 21.20 (C-35-OCOCH3), 21.17 (C-12), 
21.8 (C-24), 23.0 (C-16), 24.2 (C-11), 26.4 (C-31), 27.6 (C-20), 31.1 (C-30), 33.47 (C-
S24	  
	  
4), 33.5 (C-7), 33.6 (C-23), 34.0 (C-15), 36.3 (C-22), 37.6 (C-10), 40.5 (C-1), 41.8 (C-
19), 41.9 (C-8), 42.0 (C-14), 42.3 (C-3), 44.6 (C-18), 46.1 (C-21), 49.5 (C-13), 50.6 (C-
9), 54.6 (C-17), 56.4 (C-5), 62.4 (C-35), 69.8 (C-34), 71.9 (C-32), 72.2 (C-33), 169.9 (C-
33-OCOCH3), 170.2 (C-34-OCOCH3), 170.6 (C-32-OCOCH3), 170.9 (C-35-OCOCH3); 
HRMS m/z (ES+): [Calculated for C43H70NaO8+ 737.4963; found 737.4980]; LRMS m/z 
(ES+) 737.5 ([M+Na]+, 100%).  
 
2-Methyl bacteriohopanetetrol (2Me-BHT, 15)  
 
Refer to Large scale total lipid extraction and Hopanoid purification by silica gel 
and HPLC (Page S9) for purification procedure. The optimum solvent to dissolve 
compound 15 for NMR experiments was found to be THF. The purity of the sample was 
~90%, judged by signals in the 1H NMR spectrum. Trials on further cleaning up the 
samples were not successful. Compound 15: Rf 0.88 (water: 2-propanol: EtOAc = 
1:8:10);  [α] D
20 = +33 (c 0.1, THF); νmax (ATR)/cm-1  3346 (νN-H, νO-H), 2927 (νC-H), 1457 
(νC-H), 1066 (νC-O); 1H NMR (500 MHz, D8-THF) δ 0.76 (s, 3H, H-28), 0.83 (d, 3H, J 6.4 
Hz, H-36), 0.85 (s, 3H, H-25), 0.86-0.92 (m, 1H, H-1a), 0.90 (s, 3H, H-24), 0.89-0.95 (m, 
1H, H-19a), 0.93 (s, 3H, H-23), 0.95 (d, 3H, H-29), 0.977 (s, 3H, H-27), 0.980(s, 3H, H-
26), 1.14 (bd, 1H, J 12.6 Hz, H-3a), 1.16-1.35 (m, 6H, H-30a, H-7e, H-3e, H-15a, H-17, 
H-9), 1.36-1.66 (m, 17H, H-13, H-15e, H-12a, H-11e, H-6a, H-6e, H-31a, H-7a, H-11a, H-
1e, H-12e, H-22, H-30b, H-19e, H-31b, H-16a, H-20a), 1.64-1.71 (m, 1H, H-2), 1.71-1.87 
(m, 3H, H-16e, H-21, H-20e), 3.30 (t, 1H, J 8.5 Hz, H-33), 3.48-3.68 (m, 3H, H-35a, H-
32, H-34), 3.65 (dd, 1H, J 3.2, 9.8 Hz, H-35b); 13C NMR (125 MHz, MeOD:CDCl3 = 1:5) 
δ 15.8 (C-28), 16.0 (C-27), 16.3 (C-26), 19.9 (C-6, C-29), 21.7 (C-23), 21.9 (C-12), 22.8 
(C-36), 23.1 (C-16), 24.2 (C-11), 24.7 (C-2), 25.9 (C-25), 27.6 (C-20), 29.3 (C-31), 30.9 
(C-24), 31.5 (C-30), 32.4 (C-4), 32.5 (C-7), 33.7 (C-15), 36.9 (C-22), 37.8 (C-10), 41.65 
(C-8), 41.70 (C-19), 41.85 (C-14), 44.3 (C-18), 45.1 (C-3), 46.2 (C-21), 49.6 (C-5), 49.7 
(C-1, C-13), 50.9 (C-9), 54.5 (C-17), 63.2 (C-35), 72.9 (C-34), 73.7 (C-32), 74.4 (C-33). 
HRMS m/z (ES+) [Calculated for C36H64NaO4+ 583.4697; found 583.4705].   
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